![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Bcn Peptides S.a. St Quinti De Mediona Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Goserelin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-183 - Rev 01
This Chemical Type CEP, issued on June 12, 2014, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1636 associated with this CEP further emphasizes